{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:39:22Z","timestamp":1774658362009,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1023\/a:1011988918476","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T06:29:09Z","timestamp":1040624949000},"page":"931-935","source":"Crossref","is-referenced-by-count":12,"title":["Triazene Drug Metabolites: Part 15. Synthesis and Plasma Hydrolysis of Anticancer Triazenes Containing Amino Acid Carriers"],"prefix":"10.1007","volume":"15","author":[{"given":"Emilia","family":"Carvalho","sequence":"first","affiliation":[]},{"given":"Jim","family":"Iley","sequence":"additional","affiliation":[]},{"given":"Maria de Jesus","family":"Perry","sequence":"additional","affiliation":[]},{"given":"Eduarda","family":"Rosa","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"303914_CR1","volume-title":"Therapeutic Drugs","year":"1991","unstructured":"\u201cTherapeutic Drugs,\u201d Ed. Sir Collin Dollery, Churchill Livingstone, London. 1991."},{"key":"303914_CR2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0006-2952(76)90207-0","volume":"25","author":"T. A. Connors","year":"1976","unstructured":"T. A. Connors, P. M. Goddard, K. Merai, W. C. J. Ross, and D. E. V. Wilman. Tumour inhibitory triazenes: structural requirements for an active metabolite. Biochem. Pharmacol.\n25:241-246 (1976).","journal-title":"Biochem. Pharmacol."},{"key":"303914_CR3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1021\/i300002a011","volume":"20","author":"M. Julliard","year":"1981","unstructured":"M. Julliard and G. Vernin. Biological properties of antitumor triazenes. Ind. Eng. Chem. Prod. Res. Rev.\n20:287-296 (1981).","journal-title":"Ind. Eng. Chem. Prod. Res. Rev."},{"key":"303914_CR4","first-page":"140","volume":"48","author":"C. J. Rutty","year":"1983","unstructured":"C. J. Rutty, D. R. Newell, R. B. Vincent, G. Abel, P. M. Goddard, S. J. Harland, and A. H. Calvert. The species dependent pharmacokinetics of DTIC. Brit. J. Cancer\n48:140 (1983).","journal-title":"Brit. J. Cancer"},{"key":"303914_CR5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1039\/P29870001503","volume":"2","author":"J. Iley","year":"1987","unstructured":"J. Iley, R. Moreira, and E. Rosa. Triazene Drug Metabolites. Part 4. Kinetics and Mechanism of the Decomposition of 1-Aryl-3-benzoyloxymethyl-3-methyltriazenes in Mixed Aqueous-Organic Solvents. J. Chem. Soc. Perkin Trans.\n2:1503-1508 (1987).","journal-title":"J. Chem. Soc. Perkin Trans."},{"key":"303914_CR6","first-page":"264","volume":"S","author":"L. Fernandes","year":"1987","unstructured":"L. Fernandes, J. Iley, and E. Rosa. Triazene Drug Metabolites. Part 5. A Simple Direct Synthesis of 3-Alkoxymethyl-and 3-Alkanethiomethyl-1-aryl-3-alkyltriazenes from 1-Aryl-3-hydroxymethyl-3-alkyltriazenes. J. Chem. Res.\n(S):264-265 (1987).","journal-title":"J. Chem. Res."},{"key":"303914_CR7","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1039\/p19910003241","volume":"2","author":"J. Iley","year":"1991","unstructured":"J. Iley, R. Moreira and E. Rosa. Triazene Drug Metabolites. Part 11. Synthesis of S-cysteinyl and related derivatives of N-hydroxymethyltriazenes. J. Chem. Soc. Perkin Trans.\n2:3241-3244 (1991).","journal-title":"J. Chem. Soc. Perkin Trans."},{"key":"303914_CR8","doi-asserted-by":"crossref","unstructured":"A. S. Clark, B. Deans, M. F. G. Stevens, M. J. Tisdale, R. T. Wheelhouse, B. J. Denny, and J. A. Hartley. Antitumour Imidazotetrazines. 32. Synthesis of Novel Imidazotetrazines and Related Bicyclic Heterocycles To Probe the Mode of Action of the Antitumour Drug Temozolide. J. Med. Chem. 1493-1504 (1995).","DOI":"10.1021\/jm00009a010"},{"key":"303914_CR9","first-page":"162","volume":"S","author":"J. Iley","year":"1989","unstructured":"J. Iley, G. Ruecroft, E. Carvalho, and E. Rosa. Triazene Drug Metabolites, Part 9. Base catalysed deacylation of 3-acyl-3-alkyl-1-aryltriazenes in ethanol. J. Chem. Soc. Res.\n(S):162-163 (1989).","journal-title":"J. Chem. Soc. Res."},{"key":"303914_CR10","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1039\/p29930000865","volume":"2","author":"E. Carvalho","year":"1993","unstructured":"E. Carvalho, J. Iley, and E. Rosa. Triazene Drug Metabolites Part 13. The decomposition of-3-acyl-3-alkyl-1-aryltriazenes in aqueous sulfuric acid. J. Chem. Soc. Perkin Trans.\n2:865-870 (1993).","journal-title":"J. Chem. Soc. Perkin Trans."},{"key":"303914_CR11","first-page":"320","volume":"S","author":"S. C. Cheng","year":"1983","unstructured":"S. C. Cheng and J. Iley. Synthesis of 1-aryl-3-methyltriazenes by base-promoted decomposition of 1-aryl-3-hydroxymethyl-3-methyltriazenes. J. Chem. Soc. Res.\n(S):320-321 (1983).","journal-title":"J. Chem. Soc. Res."},{"issue":"4","key":"303914_CR12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/03602538708994129","volume":"18","author":"F. Leinweber","year":"1987","unstructured":"Franz-Josef Leinweber. Possible physiological roles of carboxylic ester hydrolyses. Drug Metabolism Reviews\n18(4):379-439 (1987).","journal-title":"Drug Metabolism Reviews"},{"issue":"4","key":"303914_CR13","first-page":"395","volume":"25","author":"A. Salvi","year":"1997","unstructured":"A. Salvi, P-A. Carrupt, J. M. Meyer, and B. Testa. Esterase-like activity of human serum albumin toward prodrug esters of nicotinic acid. Drug Metab. Dispos.\n25(4):395-398 (1997).","journal-title":"Drug Metab. Dispos."},{"issue":"8","key":"303914_CR14","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jps.2600700815","volume":"70","author":"F. Delben","year":"1981","unstructured":"F. Delben, S. Paoletti, G. Manzini, and C. Nisi. Influence of serum albumins on decomposition rates of para-substituted 1-phenyl-3-methyltriazenes and 5-(3-methyl-1-triazeno)imidazole-4-carboxamide in near physiological conditions. J. Pharm. Sci.\n70(8):892-897 (1981).","journal-title":"J. Pharm. Sci."},{"key":"303914_CR15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/jps.2600840426","volume":"84","author":"T. G. Burke","year":"1995","unstructured":"T. G. Burke, C. B. Munshi, Z. Mings, and Y. Jiang. The important role of albumin in determining the relative human blood stabilities of the camptothecin anticancer drugs, J. Pharm. Sci.\n84:518-519 (1995).","journal-title":"J. Pharm. Sci."},{"key":"303914_CR16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.2042-7158.1980.tb12991.x","volume":"32","author":"L. Aarons","year":"1980","unstructured":"L. Aarons, P. Clifon, G. Fleming, and M. Rowland. Aspirin binding and the effect of albumin on spontaneous and enzyme catalysed hydrolysis. J. Pharm. Pharmacol.\n32:537-543 (1980).","journal-title":"J. Pharm. Pharmacol."},{"key":"303914_CR17","volume-title":"Biochemistry","author":"A. L. Lehninger","year":"1975","unstructured":"A. L. Lehninger. Biochemistry 2nd Edn., Worth Publishers Inc., New York. 1975, ch. 30.","edition":"2nd Edn."},{"key":"303914_CR18","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1071\/CH9661197","volume":"19","author":"R. W. Hay","year":"1966","unstructured":"R. W. Hay, L. J. Porter, and P. J. Morris. The basic hydrolysis of aminoacid esters. Aust. J. Chem.\n19:1197-1205 (1966).","journal-title":"Aust. J. Chem."},{"key":"303914_CR19","first-page":"113","volume-title":"A Textbook of Drug Design and Development","author":"H. Bundgaard","year":"1991","unstructured":"Hans Bundgaard. Design and application of prodrugs. In P. Krogsgaard-Larsen and H. Bundgaard (eds.), A Textbook of Drug Design and Development, Harwood Academic Publishers, Philadelphia, 1991, pp. 113-192."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1011988918476.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1011988918476\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1011988918476.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T07:35:23Z","timestamp":1754033723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1011988918476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["303914"],"URL":"https:\/\/doi.org\/10.1023\/a:1011988918476","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}